Skip to main navigation Skip to search Skip to main content

Aerosolized chemically modified tetracycline nanoformulation for the treatment of acute respiratory distress syndrome

Project: Research

Project Details

StatusActive
Effective start/end date03/1/24 → 02/28/27

Funding

  • National Heart Lung and Blood Institute: $160,362.00